ARTICLE | Clinical News
Proteo Biotech preclinical data
July 19, 2004 7:00 AM UTC
In a rodent model, high doses of intravenous Elafin did not cause any toxic reactions. The recombinant elastase and proteinase 3 inhibitor also reduced tissue damage caused by blood supply deficienci...